QFREF yields 158.73% · PFE yields 6.20%● Live data
📍 QFREF pulled ahead of the other in Year 1
Combined, QFREF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QFREF + PFE for your $10,000?
Q-Free ASA supplies intelligent transportation system products and solutions worldwide. It offers tolling products, such as dedicated short-range communication on-board units, roadside transceivers/antennas, handheld transceivers/digital tachographs, and automated license plate recognition (ALPR) cameras/imaging systems. The company also provides Intrada ALPR, an automatic license plate recognition and vehicle analytics solution; Intrada Insight, an image processing and review solution; and Intrada Synergy Server, an image processing solution for video-based passages, such as tolling and parking/access control. In addition, it offers traffic management products, including Urban hardware, such as ATC controllers and cabinets; urban software comprising central and local traffic control software systems, as well as ramp meter, analytics, adaptive, and connected vehicle software enhancements; interurban software, such as Statewide ATMS, a statewide freeway traffic management software system, as well as software enhancements for work zone and event management; and infomobility hardware products, including high- and low-speed weigh-in-motion systems, as well as traffic counting and classification products for vehicles, bicycles, and pedestrians. The company also provides maintenance services. Q-Free ASA was founded in 1984 and is headquartered in Trondheim, Norway.
Full QFREF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.